Andover, MA, United States of America

Pierre Boulas

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Biogen Ma Inc.. Active years: 2022.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pierre Boulas: Innovator in Pharmaceutical Compositions

Introduction

Pierre Boulas is a notable inventor based in Andover, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work focuses on improving the delivery and efficacy of medications.

Latest Patents

Pierre Boulas holds a patent for "Dimethyl fumarate particles and pharmaceutical compositions thereof." This invention provides dimethyl fumarate (DMF) particles and methods for preparing these particles. Additionally, it includes DMF coated particles that are designed with an enteric coating. The invention also outlines various dosage forms and methods for treating diseases or disorders, such as multiple sclerosis.

Career Highlights

Pierre Boulas is associated with Biogen MA Inc., a leading biotechnology company that specializes in developing therapies for neurological diseases. His work at Biogen has allowed him to contribute to advancements in treatment options for patients suffering from serious conditions.

Collaborations

Some of his notable coworkers include Yiqing Lin and William F Kiesman. Their collaborative efforts have further enhanced the research and development of pharmaceutical innovations.

Conclusion

Pierre Boulas is a distinguished inventor whose work in pharmaceutical compositions has the potential to improve treatment outcomes for patients. His contributions to the field are invaluable and reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…